Ivana Magovcevic-Liebisch

Insider Reports History

Location
Watertown, MA
Signature
/s/ Bonnie McManus, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ivana Magovcevic-Liebisch:

Company Role Class Num Shares Value Price $ Report Date Ownership
Vigil Neuroscience, Inc. President and CEO, Director Stock Option Award (Right to Buy) 0 $2,818,660 $7.62 05 Aug 2025 Direct
Quanterix Corp Director Common Stock 43,607 $277,357 $6.36 02 Jan 2026 Direct
Vigil Neuroscience, Inc. President and CEO, Director Common Stock 0 $0 $8.05 05 Aug 2025 Direct
Aeglea BioTherapeutics, Inc. Director Stock Option (right to buy) 1,950,000 22 Jun 2023 Direct
Absci Corp Director Stock Option (right to buy) 28,700 08 Jun 2022 Direct
Acrivon Therapeutics, Inc. Director Stock Option (Right to Buy) 20,275 13 Jun 2025 Direct
APPLIED GENETIC TECHNOLOGIES CORP Director Stock Option (right to buy) 14,000 30 Nov 2021 Direct

Insider Reports Filed by Ivana Magovcevic-Liebisch

Symbol Company Period Transactions Value $ Form Type Role Filing Time
QTRX Quanterix Corp 02 Jan 2026 1 $0 4 Director 15 Jan 2026, 12:29
VIGL Vigil Neuroscience, Inc. 05 Aug 2025 9 $0 4 President and CEO, Director 05 Aug 2025, 09:43
ACRV Acrivon Therapeutics, Inc. 13 Jun 2025 1 $0 4 Director 17 Jun 2025, 17:48
VIGL Vigil Neuroscience, Inc. 03 Mar 2025 1 $0 4 President and CEO, Director 04 Mar 2025, 17:08
QTRX Quanterix Corp 02 Jan 2025 2 $0 4 Director 06 Jan 2025, 17:57
VIGL Vigil Neuroscience, Inc. 19 Dec 2024 1 +$8,400 4 President and CEO, Director 19 Dec 2024, 18:42
VIGL Vigil Neuroscience, Inc. 18 Dec 2024 1 +$8,350 4 President and CEO, Director 18 Dec 2024, 17:51
VIGL Vigil Neuroscience, Inc. 05 Dec 2024 1 +$11,700 4 President and CEO, Director 05 Dec 2024, 17:09
QTRX Quanterix Corp 02 Oct 2024 2 $0 4 Director 03 Oct 2024, 17:17
QTRX Quanterix Corp 02 Oct 2024 0 $0 3 Director 03 Oct 2024, 17:17
VIGL Vigil Neuroscience, Inc. 03 May 2024 4 $0 4 President and CEO, Director 07 May 2024, 17:00
VIGL Vigil Neuroscience, Inc. 01 Mar 2024 1 $0 4 President and CEO, Director 01 Mar 2024, 17:53
ACRV Acrivon Therapeutics, Inc. 08 Feb 2024 1 $0 4 Director 09 Feb 2024, 16:37
ACRV Acrivon Therapeutics, Inc. 08 Feb 2024 0 $0 3 Director 09 Feb 2024, 16:34
VIGL Vigil Neuroscience, Inc. 20 Nov 2023 1 +$15,000 4 President and CEO, Director 20 Nov 2023, 18:34
SYRE Aeglea BioTherapeutics, Inc. 22 Jun 2023 1 $0 4 Director 30 Jun 2023, 16:32
VIGL Vigil Neuroscience, Inc. 01 Mar 2023 1 $0 4 President and CEO, Director 03 Mar 2023, 16:14
ABSI Absci Corp 08 Jun 2022 1 $0 4 Director 10 Jun 2022, 16:50
SYRE Aeglea BioTherapeutics, Inc. 07 Jun 2022 1 $0 4 Director 09 Jun 2022, 21:17
VIGL Vigil Neuroscience, Inc. 02 May 2022 2 +$18,379 4 President and CEO, Director 04 May 2022, 07:00
VIGL Vigil Neuroscience, Inc. 01 Mar 2022 1 $0 4 President and CEO, Director 03 Mar 2022, 15:06
VIGL Vigil Neuroscience, Inc. 06 Jan 2022 0 $0 3 President and CEO, Director 06 Jan 2022, 19:34
/report/000106299321012057-magovcevic-liebisch-ivana-2021-11-30 APPLIED GENETIC TECHNOLOGIES CORP 30 Nov 2021 1 $0 4 Director 02 Dec 2021, 17:55
ABSI Absci Corp 21 Jul 2021 0 $0 3 Director 21 Jul 2021, 20:55
SYRE Aeglea BioTherapeutics, Inc. 08 Jun 2021 1 $0 4 Director 09 Jun 2021, 17:25